Page last updated: 2024-08-07 16:45:19
Melatonin receptor type 1B
A melatonin receptor type 1B that is encoded in the genome of human. [PRO:WCB, UniProtKB:P49286]
Synonyms
Mel-1B-R;
Mel1b receptor
Research
Bioassay Publications (67)
Timeframe | Studies on this Protein(%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (10.45) | 18.2507 |
2000's | 29 (43.28) | 29.6817 |
2010's | 23 (34.33) | 24.3611 |
2020's | 8 (11.94) | 2.80 |
Compounds (22)
Drugs with Inhibition Measurements
Drugs with Activation Measurements
Design and Validation of the First Family of Photo-Activatable Ligands for Melatonin Receptors.Journal of medicinal chemistry, , 08-25, Volume: 65, Issue:16, 2022
[no title available]Journal of medicinal chemistry, , 02-25, Volume: 64, Issue:4, 2021
[no title available]Journal of medicinal chemistry, , 03-25, Volume: 64, Issue:6, 2021
Tuning melatonin receptor subtype selectivity in oxadiazolone-based analogues: Discovery of QR2 ligands and NRF2 activators with neurogenic properties.European journal of medicinal chemistry, , Mar-15, Volume: 190, 2020
Indole-based melatonin analogues: Synthetic approaches and biological activity.European journal of medicinal chemistry, , Jan-01, Volume: 185, 2020
Polybenzyls from Gastrodia elata, their agonistic effects on melatonin receptors and structure-activity relationships.Bioorganic & medicinal chemistry, , 08-01, Volume: 27, Issue:15, 2019
[no title available]Journal of medicinal chemistry, , 09-13, Volume: 61, Issue:17, 2018
New quinolinic derivatives as melatonergic ligands: Synthesis and pharmacological evaluation.European journal of medicinal chemistry, , Feb-15, Volume: 127, 2017
Melatonergic ligands: Design, synthesis and pharmacological evaluation of novel series of naphthofuranic derivatives.European journal of medicinal chemistry, , Feb-15, Volume: 109, 2016
Synthesis of 2-arylfuro[3,2-b]pyridines: Effect of the C2-aryl group on melatoninergic activity.European journal of medicinal chemistry, , Feb-15, Volume: 109, 2016
Novel N-Acetyl Bioisosteres of Melatonin: Melatonergic Receptor Pharmacology, Physicochemical Studies, and Phenotypic Assessment of Their Neurogenic Potential.Journal of medicinal chemistry, , Jun-25, Volume: 58, Issue:12, 2015
New coumarin-based fluorescent melatonin ligands. Design, synthesis and pharmacological characterization.European journal of medicinal chemistry, , Oct-20, Volume: 103, 2015
Synthesis of new melatoninergic hexahydroindenopyridines.Bioorganic & medicinal chemistry letters, , Aug-01, Volume: 24, Issue:15, 2014
Efficient synthesis of hexahydroindenopyridines and their potential as melatoninergic ligands.European journal of medicinal chemistry, , Oct-30, Volume: 86, 2014
Development of substituted N-[3-(3-methoxylphenyl)propyl] amides as MT(2)-selective melatonin agonists: improving metabolic stability.Bioorganic & medicinal chemistry, , Jan-15, Volume: 21, Issue:2, 2013
Synthesis of new N-(arylcyclopropyl)acetamides and N-(arylvinyl)acetamides as conformationally-restricted ligands for melatonin receptors.Bioorganic & medicinal chemistry letters, , Jan-15, Volume: 23, Issue:2, 2013
Design and synthesis of 2-phenylimidazo[1,2-a]pyridines as a novel class of melatonin receptor ligands.European journal of medicinal chemistry, , Volume: 46, Issue:9, 2011
Bivalent ligand approach on N-{2-[(3-methoxyphenyl)methylamino]ethyl}acetamide: synthesis, binding affinity and intrinsic activity for MT(1) and MT(2) melatonin receptors.Bioorganic & medicinal chemistry, , Aug-15, Volume: 19, Issue:16, 2011
Design and synthesis of naphthalenic derivatives as new ligands at the melatonin binding site MT3.European journal of medicinal chemistry, , Volume: 46, Issue:5, 2011
1,6-Dihydro-2H-indeno[5,4-b]furan derivatives: design, synthesis, and pharmacological characterization of a novel class of highly potent MTâ‚‚-selective agonists.Journal of medicinal chemistry, , May-12, Volume: 54, Issue:9, 2011
Preparation and pharmacological evaluation of a novel series of 2-(phenylthio)benzo[b]thiophenes as selective MT2 receptor ligands.European journal of medicinal chemistry, , Volume: 46, Issue:5, 2011
Design and synthesis of 1-(2-alkanamidoethyl)-6-methoxy-7-azaindole derivatives as potent melatonin agonists.Bioorganic & medicinal chemistry letters, , Apr-15, Volume: 21, Issue:8, 2011
Synthesis of a novel series of tricyclic dihydrofuran derivatives: discovery of 8,9-dihydrofuro[3,2-c]pyrazolo[1,5-a]pyridines as melatonin receptor (MT1/MT2) ligands.Journal of medicinal chemistry, , Jun-23, Volume: 54, Issue:12, 2011
Design, synthesis, and pharmacological effects of structurally simple ligands for MT(1) and MT(2) melatonin receptors.Bioorganic & medicinal chemistry, , Sep-01, Volume: 18, Issue:17, 2010
Synthesis of substituted N-[3-(3-methoxyphenyl)propyl] amides as highly potent MT(2)-selective melatonin ligands.Bioorganic & medicinal chemistry letters, , Apr-15, Volume: 20, Issue:8, 2010
Design, synthesis and pharmacological evaluation of novel naphthalenic derivatives as selective MT(1) melatoninergic ligands.Bioorganic & medicinal chemistry, , May-15, Volume: 18, Issue:10, 2010
2-[(2,3-dihydro-1H-indol-1-yl)methyl]melatonin analogues: a novel class of MT2-selective melatonin receptor antagonists.Journal of medicinal chemistry, , Feb-12, Volume: 52, Issue:3, 2009
Synthesis and pharmacological evaluation of 1,2,3,4-tetrahydropyrazino[1,2-a]indole and 2-[(phenylmethylamino)methyl]-1H-indole analogues as novel melatoninergic ligands.Bioorganic & medicinal chemistry, , Jul-01, Volume: 17, Issue:13, 2009
Synthesis of 3-phenylnaphthalenic derivatives as new selective MT(2) melatoninergic ligands.Bioorganic & medicinal chemistry, , Sep-15, Volume: 16, Issue:18, 2008
Design and synthesis of benzofuranic derivatives as new ligands at the melatonin-binding site MT3.Bioorganic & medicinal chemistry, , May-01, Volume: 16, Issue:9, 2008
Synthesis and pharmacological evaluation of pentacyclic 6a,7-dihydrodiindole and 2,3-dihydrodiindole derivatives as novel melatoninergic ligands.Bioorganic & medicinal chemistry, , Aug-15, Volume: 16, Issue:16, 2008
N-(substituted-anilinoethyl)amides: design, synthesis, and pharmacological characterization of a new class of melatonin receptor ligands.Journal of medicinal chemistry, , Dec-27, Volume: 50, Issue:26, 2007
Synthesis and biological activity of new melatonin dimeric derivatives.Bioorganic & medicinal chemistry, , Jul-01, Volume: 15, Issue:13, 2007
7-Substituted-melatonin and 7-substituted-1-methylmelatonin analogues: effect of substituents on potency and binding affinity.Bioorganic & medicinal chemistry, , Jul-01, Volume: 15, Issue:13, 2007
Design, synthesis and melatoninergic activity of new unsubstituted and beta,beta'-difunctionalised 2,3-dihydro-1H-pyrrolo[3,2,1-ij]quinolin-6-alkanamides.European journal of medicinal chemistry, , Volume: 42, Issue:7, 2007
Design and synthesis of N-(3,3-diphenylpropenyl)alkanamides as a novel class of high-affinity MT2-selective melatonin receptor ligands.Journal of medicinal chemistry, , Dec-14, Volume: 49, Issue:25, 2006
Mapping the melatonin receptor. 7. Subtype selective ligands based on beta-substituted N-acyl-5-methoxytryptamines and beta-substituted N-acyl-5-methoxy-1-methyltryptamines.Journal of medicinal chemistry, , Jun-15, Volume: 49, Issue:12, 2006
Analysis of structure-activity relationships for MT2 selective antagonists by melatonin MT1 and MT2 receptor models.Journal of medicinal chemistry, , Jun-16, Volume: 48, Issue:12, 2005
(R)-2-(4-Phenylbutyl)dihydrobenzofuran derivatives as melatoninergic agents.Bioorganic & medicinal chemistry letters, , Mar-01, Volume: 15, Issue:5, 2005
N-[2-[2-(4-Phenylbutyl)benzofuran-4-yl]cyclopropylmethyl]acetamide: an orally bioavailable melatonin receptor agonist.Bioorganic & medicinal chemistry letters, , Oct-18, Volume: 14, Issue:20, 2004
4-Substituted anilides as selective melatonin MT2 receptor agonists.Bioorganic & medicinal chemistry letters, , Feb-23, Volume: 14, Issue:4, 2004
Tricyclic alkylamides as melatonin receptor ligands with antagonist or inverse agonist activity.Journal of medicinal chemistry, , Aug-12, Volume: 47, Issue:17, 2004
Synthesis and structure-activity relationship of novel benzoxazole derivatives as melatonin receptor agonists.Bioorganic & medicinal chemistry letters, , Jul-16, Volume: 14, Issue:14, 2004
Design and synthesis of benzoxazole derivatives as novel melatoninergic ligands.Bioorganic & medicinal chemistry letters, , Mar-08, Volume: 14, Issue:5, 2004
Heterocyclic aminopyrrolidine derivatives as melatoninergic agents.Bioorganic & medicinal chemistry letters, , Dec-15, Volume: 13, Issue:24, 2003
Three-dimensional quantitative structure-activity relationship studies on selected MT1 and MT2 melatonin receptor ligands: requirements for subtype selectivity and intrinsic activity modulation.Journal of medicinal chemistry, , Apr-10, Volume: 46, Issue:8, 2003
Indanyl piperazines as melatonergic MT2 selective agents.Bioorganic & medicinal chemistry letters, , Mar-24, Volume: 13, Issue:6, 2003
Design and synthesis of naphthalenic dimers as selective MT1 melatoninergic ligands.Journal of medicinal chemistry, , Mar-27, Volume: 46, Issue:7, 2003
Synthesis and structure-affinity-activity relationships of novel benzofuran derivatives as MT(2) melatonin receptor selective ligands.Journal of medicinal chemistry, , Jun-20, Volume: 45, Issue:13, 2002
Synthesis of nitroindole derivatives with high affinity and selectivity for melatoninergic binding sites MT(3).Journal of medicinal chemistry, , Apr-25, Volume: 45, Issue:9, 2002
Synthesis of a novel series of benzocycloalkene derivatives as melatonin receptor agonists.Journal of medicinal chemistry, , Sep-12, Volume: 45, Issue:19, 2002
Synthesis of a novel series of tricyclic indan derivatives as melatonin receptor agonists.Journal of medicinal chemistry, , Sep-12, Volume: 45, Issue:19, 2002
2-N-acylaminoalkylindoles: design and quantitative structure-activity relationship studies leading to MT2-selective melatonin antagonists.Journal of medicinal chemistry, , Aug-30, Volume: 44, Issue:18, 2001
Mapping the melatonin receptor. 6. Melatonin agonists and antagonists derived from 6H-isoindolo[2,1-a]indoles, 5,6-dihydroindolo[2,1-a]isoquinolines, and 6,7-dihydro-5H-benzo[c]azepino[2,1-a]indoles.Journal of medicinal chemistry, , Mar-23, Volume: 43, Issue:6, 2000
Synthesis of phenalene and acenaphthene derivatives as new conformationally restricted ligands for melatonin receptors.Journal of medicinal chemistry, , Nov-02, Volume: 43, Issue:22, 2000
Melatonin receptor ligands: synthesis of new melatonin derivatives and comprehensive comparative molecular field analysis (CoMFA) study.Journal of medicinal chemistry, , Sep-24, Volume: 41, Issue:20, 1998
Development of a high-affinity ligand that binds irreversibly to Mel1b melatonin receptors.Journal of medicinal chemistry, , Dec-19, Volume: 40, Issue:26, 1997
1-(2-Alkanamidoethyl)-6-methoxyindole derivatives: a new class of potent indole melatonin analogues.Journal of medicinal chemistry, , Jun-20, Volume: 40, Issue:13, 1997
Conformationally restrained melatonin analogues: synthesis, binding affinity for the melatonin receptor, evaluation of the biological activity, and molecular modeling study.Journal of medicinal chemistry, , Jun-20, Volume: 40, Issue:13, 1997
Synthesis and structure-activity relationships of novel naphthalenic and bioisosteric related amidic derivatives as melatonin receptor ligands.Journal of medicinal chemistry, , Sep-30, Volume: 37, Issue:20, 1994
2-Substituted 5-methoxy-N-acyltryptamines: synthesis, binding affinity for the melatonin receptor, and evaluation of the biological activity.Journal of medicinal chemistry, , Dec-10, Volume: 36, Issue:25, 1993
2-Amido-8-methoxytetralins: a series of nonindolic melatonin-like agents.Journal of medicinal chemistry, , Oct-01, Volume: 36, Issue:20, 1993
Indole-based melatonin analogues: Synthetic approaches and biological activity.European journal of medicinal chemistry, , Jan-01, Volume: 185, 2020
MT1 and MT2 melatonin receptors: ligands, models, oligomers, and therapeutic potential.Journal of medicinal chemistry, , Apr-24, Volume: 57, Issue:8, 2014
1-(2-Alkanamidoethyl)-6-methoxyindole derivatives: a new class of potent indole melatonin analogues.Journal of medicinal chemistry, , Jun-20, Volume: 40, Issue:13, 1997
Conformationally restrained melatonin analogues: synthesis, binding affinity for the melatonin receptor, evaluation of the biological activity, and molecular modeling study.Journal of medicinal chemistry, , Jun-20, Volume: 40, Issue:13, 1997
2-Substituted 5-methoxy-N-acyltryptamines: synthesis, binding affinity for the melatonin receptor, and evaluation of the biological activity.Journal of medicinal chemistry, , Dec-10, Volume: 36, Issue:25, 1993
2-Amido-8-methoxytetralins: a series of nonindolic melatonin-like agents.Journal of medicinal chemistry, , Oct-01, Volume: 36, Issue:20, 1993
Synthesis and biological evaluation of paeoveitol D derivatives as new melatonin receptor agonists with antidepressant activities.RSC medicinal chemistry, , Oct-19, Volume: 13, Issue:10, 2022
Quinazoline and phthalazine derivatives as novel melatonin receptor ligands analogues of agomelatine.European journal of medicinal chemistry, , Mar-01, Volume: 189, 2020
New quinolinic derivatives as melatonergic ligands: Synthesis and pharmacological evaluation.European journal of medicinal chemistry, , Feb-15, Volume: 127, 2017
[no title available]European journal of medicinal chemistry, , Dec-01, Volume: 141, 2017
Melatonergic ligands: Design, synthesis and pharmacological evaluation of novel series of naphthofuranic derivatives.European journal of medicinal chemistry, , Feb-15, Volume: 109, 2016
Synthesis of new N-(arylcyclopropyl)acetamides and N-(arylvinyl)acetamides as conformationally-restricted ligands for melatonin receptors.Bioorganic & medicinal chemistry letters, , Jan-15, Volume: 23, Issue:2, 2013
Design, synthesis and pharmacological evaluation of novel naphthalenic derivatives as selective MT(1) melatoninergic ligands.Bioorganic & medicinal chemistry, , May-15, Volume: 18, Issue:10, 2010
Synthesis of 3-phenylnaphthalenic derivatives as new selective MT(2) melatoninergic ligands.Bioorganic & medicinal chemistry, , Sep-15, Volume: 16, Issue:18, 2008
Design and synthesis of naphthalenic dimers as selective MT1 melatoninergic ligands.Journal of medicinal chemistry, , Mar-27, Volume: 46, Issue:7, 2003
Synthesis of phenalene and acenaphthene derivatives as new conformationally restricted ligands for melatonin receptors.Journal of medicinal chemistry, , Nov-02, Volume: 43, Issue:22, 2000
Synthesis and structure-activity relationships of novel naphthalenic and bioisosteric related amidic derivatives as melatonin receptor ligands.Journal of medicinal chemistry, , Sep-30, Volume: 37, Issue:20, 1994
MT1 and MT2 melatonin receptors: ligands, models, oligomers, and therapeutic potential.Journal of medicinal chemistry, , Apr-24, Volume: 57, Issue:8, 2014
Synthesis of nitroindole derivatives with high affinity and selectivity for melatoninergic binding sites MT(3).Journal of medicinal chemistry, , Apr-25, Volume: 45, Issue:9, 2002
2-Substituted 5-methoxy-N-acyltryptamines: synthesis, binding affinity for the melatonin receptor, and evaluation of the biological activity.Journal of medicinal chemistry, , Dec-10, Volume: 36, Issue:25, 1993
2-Amido-8-methoxytetralins: a series of nonindolic melatonin-like agents.Journal of medicinal chemistry, , Oct-01, Volume: 36, Issue:20, 1993
MT1 and MT2 melatonin receptors: ligands, models, oligomers, and therapeutic potential.Journal of medicinal chemistry, , Apr-24, Volume: 57, Issue:8, 2014
Design, synthesis and melatoninergic activity of new unsubstituted and beta,beta'-difunctionalised 2,3-dihydro-1H-pyrrolo[3,2,1-ij]quinolin-6-alkanamides.European journal of medicinal chemistry, , Volume: 42, Issue:7, 2007
Mapping the melatonin receptor. 6. Melatonin agonists and antagonists derived from 6H-isoindolo[2,1-a]indoles, 5,6-dihydroindolo[2,1-a]isoquinolines, and 6,7-dihydro-5H-benzo[c]azepino[2,1-a]indoles.Journal of medicinal chemistry, , Mar-23, Volume: 43, Issue:6, 2000
1-(2-Alkanamidoethyl)-6-methoxyindole derivatives: a new class of potent indole melatonin analogues.Journal of medicinal chemistry, , Jun-20, Volume: 40, Issue:13, 1997
Conformationally restrained melatonin analogues: synthesis, binding affinity for the melatonin receptor, evaluation of the biological activity, and molecular modeling study.Journal of medicinal chemistry, , Jun-20, Volume: 40, Issue:13, 1997
2-Substituted 5-methoxy-N-acyltryptamines: synthesis, binding affinity for the melatonin receptor, and evaluation of the biological activity.Journal of medicinal chemistry, , Dec-10, Volume: 36, Issue:25, 1993
Indole-based melatonin analogues: Synthetic approaches and biological activity.European journal of medicinal chemistry, , Jan-01, Volume: 185, 2020
MT1 and MT2 melatonin receptors: ligands, models, oligomers, and therapeutic potential.Journal of medicinal chemistry, , Apr-24, Volume: 57, Issue:8, 2014
[no title available]Journal of medicinal chemistry, , 03-25, Volume: 64, Issue:6, 2021
Synthesis of a novel series of tricyclic indan derivatives as melatonin receptor agonists.Journal of medicinal chemistry, , Sep-12, Volume: 45, Issue:19, 2002
MT1 and MT2 melatonin receptors: ligands, models, oligomers, and therapeutic potential.Journal of medicinal chemistry, , Apr-24, Volume: 57, Issue:8, 2014
2-[(2,3-dihydro-1H-indol-1-yl)methyl]melatonin analogues: a novel class of MT2-selective melatonin receptor antagonists.Journal of medicinal chemistry, , Feb-12, Volume: 52, Issue:3, 2009
Analysis of structure-activity relationships for MT2 selective antagonists by melatonin MT1 and MT2 receptor models.Journal of medicinal chemistry, , Jun-16, Volume: 48, Issue:12, 2005
Synthesis and biological evaluation of paeoveitol D derivatives as new melatonin receptor agonists with antidepressant activities.RSC medicinal chemistry, , Oct-19, Volume: 13, Issue:10, 2022
1-(2-Alkanamidoethyl)-6-methoxyindole derivatives: a new class of potent indole melatonin analogues.Journal of medicinal chemistry, , Jun-20, Volume: 40, Issue:13, 1997
Conformationally restrained melatonin analogues: synthesis, binding affinity for the melatonin receptor, evaluation of the biological activity, and molecular modeling study.Journal of medicinal chemistry, , Jun-20, Volume: 40, Issue:13, 1997
2-Substituted 5-methoxy-N-acyltryptamines: synthesis, binding affinity for the melatonin receptor, and evaluation of the biological activity.Journal of medicinal chemistry, , Dec-10, Volume: 36, Issue:25, 1993
MT1 and MT2 melatonin receptors: ligands, models, oligomers, and therapeutic potential.Journal of medicinal chemistry, , Apr-24, Volume: 57, Issue:8, 2014
Mapping the melatonin receptor. 6. Melatonin agonists and antagonists derived from 6H-isoindolo[2,1-a]indoles, 5,6-dihydroindolo[2,1-a]isoquinolines, and 6,7-dihydro-5H-benzo[c]azepino[2,1-a]indoles.Journal of medicinal chemistry, , Mar-23, Volume: 43, Issue:6, 2000
MT1 and MT2 melatonin receptors: ligands, models, oligomers, and therapeutic potential.Journal of medicinal chemistry, , Apr-24, Volume: 57, Issue:8, 2014
2-[(2,3-dihydro-1H-indol-1-yl)methyl]melatonin analogues: a novel class of MT2-selective melatonin receptor antagonists.Journal of medicinal chemistry, , Feb-12, Volume: 52, Issue:3, 2009
Analysis of structure-activity relationships for MT2 selective antagonists by melatonin MT1 and MT2 receptor models.Journal of medicinal chemistry, , Jun-16, Volume: 48, Issue:12, 2005
Mapping the melatonin receptor. 6. Melatonin agonists and antagonists derived from 6H-isoindolo[2,1-a]indoles, 5,6-dihydroindolo[2,1-a]isoquinolines, and 6,7-dihydro-5H-benzo[c]azepino[2,1-a]indoles.Journal of medicinal chemistry, , Mar-23, Volume: 43, Issue:6, 2000
MT1 and MT2 melatonin receptors: ligands, models, oligomers, and therapeutic potential.Journal of medicinal chemistry, , Apr-24, Volume: 57, Issue:8, 2014
2-[(2,3-dihydro-1H-indol-1-yl)methyl]melatonin analogues: a novel class of MT2-selective melatonin receptor antagonists.Journal of medicinal chemistry, , Feb-12, Volume: 52, Issue:3, 2009
Analysis of structure-activity relationships for MT2 selective antagonists by melatonin MT1 and MT2 receptor models.Journal of medicinal chemistry, , Jun-16, Volume: 48, Issue:12, 2005
2-N-acylaminoalkylindoles: design and quantitative structure-activity relationship studies leading to MT2-selective melatonin antagonists.Journal of medicinal chemistry, , Aug-30, Volume: 44, Issue:18, 2001
Enables
This protein enables 3 target(s):
Target | Category | Definition |
protein binding | molecular function | Binding to a protein. [GOC:go_curators] |
melatonin receptor activity | molecular function | Combining with melatonin, N-acetyl-5-methoxytryptamine, to initiate a change in cell activity. Melatonin is a neuroendocrine substance that stimulates the aggregation of melanosomes in melanophores, thus lightening the skin. [GOC:ai, ISBN:0198506732] |
G protein-coupled receptor activity | molecular function | Combining with an extracellular signal and transmitting the signal across the membrane by activating an associated G-protein; promotes the exchange of GDP for GTP on the alpha subunit of a heterotrimeric G-protein complex. [GOC:bf, http://www.iuphar-db.org, Wikipedia:GPCR] |
Located In
This protein is located in 2 target(s):
Target | Category | Definition |
plasma membrane | cellular component | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. [ISBN:0716731363] |
synapse | cellular component | The junction between an axon of one neuron and a dendrite of another neuron, a muscle fiber or a glial cell. As the axon approaches the synapse it enlarges into a specialized structure, the presynaptic terminal bouton, which contains mitochondria and synaptic vesicles. At the tip of the terminal bouton is the presynaptic membrane; facing it, and separated from it by a minute cleft (the synaptic cleft) is a specialized area of membrane on the receiving cell, known as the postsynaptic membrane. In response to the arrival of nerve impulses, the presynaptic terminal bouton secretes molecules of neurotransmitters into the synaptic cleft. These diffuse across the cleft and transmit the signal to the postsynaptic membrane. [GOC:aruk, ISBN:0198506732, PMID:24619342, PMID:29383328, PMID:31998110] |
Active In
This protein is active in 1 target(s):
Target | Category | Definition |
plasma membrane | cellular component | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. [ISBN:0716731363] |
Involved In
This protein is involved in 15 target(s):
Target | Category | Definition |
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | biological process | A G protein-coupled receptor signaling pathway in which the signal is transmitted via the activation or inhibition of a nucleotide cyclase activity and a subsequent change in the concentration of a cyclic nucleotide. [GOC:mah, GOC:signaling, ISBN:0815316194] |
chemical synaptic transmission | biological process | The vesicular release of classical neurotransmitter molecules from a presynapse, across a chemical synapse, the subsequent activation of neurotransmitter receptors at the postsynapse of a target cell (neuron, muscle, or secretory cell) and the effects of this activation on the postsynaptic membrane potential and ionic composition of the postsynaptic cytosol. This process encompasses both spontaneous and evoked release of neurotransmitter and all parts of synaptic vesicle exocytosis. Evoked transmission starts with the arrival of an action potential at the presynapse. [GOC:jl, MeSH:D009435] |
negative regulation of cGMP-mediated signaling | biological process | Any process that decreases the rate, frequency or extent of cGMP-mediated signaling. [GOC:BHF, GOC:dph, GOC:tb] |
glucose homeostasis | biological process | Any process involved in the maintenance of an internal steady state of glucose within an organism or cell. [GOC:go_curators] |
camera-type eye development | biological process | The process whose specific outcome is the progression of the camera-type eye over time, from its formation to the mature structure. The camera-type eye is an organ of sight that receives light through an aperture and focuses it through a lens, projecting it on a photoreceptor field. [GOC:go_curators, GOC:mtg_sensu] |
negative regulation of neuron apoptotic process | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process in neurons. [GOC:go_curators, GOC:mtg_apoptosis] |
negative regulation of vasoconstriction | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of vasoconstriction. [GOC:go_curators] |
positive regulation of circadian sleep/wake cycle, non-REM sleep | biological process | Any process that activates or increases the duration or quality of non-rapid eye movement (NREM) sleep. [GOC:go_curators] |
negative regulation of insulin secretion | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of insulin. [GOC:ai] |
regulation of insulin secretion | biological process | Any process that modulates the frequency, rate or extent of the regulated release of insulin. [GOC:ai] |
negative regulation of cytosolic calcium ion concentration | biological process | Any process that decreases the concentration of calcium ions in the cytosol. [GOC:ai] |
negative regulation of transmission of nerve impulse | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of transmission of a nerve impulse, the sequential electrochemical polarization and depolarization that travels across the membrane of a neuron in response to stimulation. [GOC:ai] |
positive regulation of transmission of nerve impulse | biological process | Any process that activates, maintains or increases the frequency, rate or extent of transmission of a nerve impulse, the sequential electrochemical polarization and depolarization that travels across the membrane of a neuron in response to stimulation. [GOC:ai] |
regulation of neuronal action potential | biological process | Any process that modulates the frequency, rate or extent of action potential creation, propagation or termination in a neuron. This typically occurs via modulation of the activity or expression of voltage-gated ion channels. [GOC:dph, GOC:isa_complete, GOC:tb] |
G protein-coupled receptor signaling pathway | biological process | The series of molecular signals initiated by a ligand binding to its receptor, in which the activated receptor promotes the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The GTP-bound activated alpha-G-protein then dissociates from the beta- and gamma-subunits to further transmit the signal within the cell. The pathway begins with receptor-ligand interaction, and ends with regulation of a downstream cellular process. The pathway can start from the plasma membrane, Golgi or nuclear membrane. [GOC:bf, GOC:mah, PMID:16902576, PMID:24568158, Wikipedia:G_protein-coupled_receptor] |